180 related articles for article (PubMed ID: 29176965)
1. Down Modulation of Host Immune Response by Amino Acid Repeats Present in a
Toro Acevedo CA; Valente BM; Burle-Caldas GA; Galvão-Filho B; Santiago HDC; Esteves Arantes RM; Junqueira C; Gazzinelli RT; Roffê E; Teixeira SMR
Front Microbiol; 2017; 8():2188. PubMed ID: 29176965
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of ribonucleoproteic antigens containing repeated amino acid sequences from Trypanosoma cruzi.
Pais FS; DaRocha WD; Almeida RM; Leclercq SY; Penido ML; Fragoso SP; Bartholomeu DC; Gazzinelli RT; Teixeira SM
Microbes Infect; 2008 Jun; 10(7):716-25. PubMed ID: 18538614
[TBL] [Abstract][Full Text] [Related]
3. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
4. Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi.
Matos MN; Cazorla SI; Schulze K; Ebensen T; Guzmán CA; Malchiodi EL
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005300. PubMed ID: 28234897
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
Burle-Caldas GA; Dos Santos NSA; de Castro JT; Mugge FLB; Grazielle-Silva V; Oliveira AER; Pereira MCA; Reis-Cunha JL; Dos Santos AC; Gomes DA; Bartholomeu DC; Moretti NS; Schenkman S; Gazzinelli RT; Teixeira SMR
mBio; 2022 Feb; 13(1):e0347821. PubMed ID: 35073735
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
Taibi A; Espinoza AG; Ouaissi A
Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
8. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
[TBL] [Abstract][Full Text] [Related]
10. A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.
Santori F R; Paranhos-Bacalla GS; Franco DA Silveira J; Yamauchi LM; Araya JE; Yoshida N
Infect Immun; 1996 Apr; 64(4):1093-9. PubMed ID: 8606064
[TBL] [Abstract][Full Text] [Related]
11. Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.
Farrow AL; Rachakonda G; Gu L; Krendelchtchikova V; Nde PN; Pratap S; Lima MF; Villalta F; Matthews QL
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3089. PubMed ID: 25144771
[TBL] [Abstract][Full Text] [Related]
12. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
Basso B; Moretti ER; Vottero-Cima E
Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
[TBL] [Abstract][Full Text] [Related]
13. Resistance to Trypanosoma cruzi induced by immunization with antigens isolated by affinity chromatography.
Araujo FG
Braz J Med Biol Res; 1984; 17(2):157-64. PubMed ID: 6440611
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins.
Motrán CC; Cerbán FM; Rivarola W; Iosa D; Vottero de Cima E
Exp Parasitol; 1998 Mar; 88(3):223-30. PubMed ID: 9562426
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: immune response in mice immunized with parasite antigens.
Rottenberg ME; Cardoni RL; deTitto EH; Moreno M; Segura EL
Exp Parasitol; 1988 Feb; 65(1):101-8. PubMed ID: 2892694
[TBL] [Abstract][Full Text] [Related]
16. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection.
Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM
Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
19. Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor
Soprano LL; Ferrero MR; Landoni M; García GA; Esteva MI; Couto AS; Duschak VG
Front Cell Infect Microbiol; 2021; 11():814276. PubMed ID: 35059328
[No Abstract] [Full Text] [Related]
20. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
Pereira VR; Lorena VM; Nakazawa M; Luna CF; Silva ED; Ferreira AG; Krieger MA; Goldenberg S; Soares MB; Coutinho EM; Correa-Oliveira R; Gomes YM
Parasitol Res; 2005 Jun; 96(3):154-61. PubMed ID: 15856302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
